Preparation of gadolinium-containing emulsions stabilized with phosphatidylcholine-surfactant mixtures for neutron-capture therapy

Chemical and Pharmaceutical Bulletin

Volumn 47, Issue 2, 1999, Pages 203-208

  Miyamoto, Masahito ^a   Hirano, Kaoru ^a   Ichikawa, Hideki ^a   Fukumori, Yoshinobu ^a   Akine, Yasuyuki ^b   Tokuuye, Koichi ^c  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Co surfactant; Gadolinium; Gd diethylenetriaminepentaacetic acid distearylamide; Lipid emulsion; Neutron capture therapy; Ultrafine emulsion

Indexed keywords

EMULSIFYING AGENT; GADOLINIUM PENTETATE DERIVATIVE; LIPID EMULSION; MACROGOL STEARATE; PHOSPHATIDYLCHOLINE; POLIDOCANOL; POLOXAMER; POLYSORBATE 80; RICINOMACROGOL; SOYBEAN OIL; SURFACTANT; WATER OIL CREAM;

DRUG DETERMINATION; DRUG FORMULATION; EMULSION; NEUTRON CAPTURE THERAPY; PARTICLE SIZE; REVIEW; SURFACE TENSION;

EID: 0032935155     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.47.203     Document Type: Review

References (25)

1. Miyamoto M., Ichikawa H., Fukumori Y., Akine Y., Tokuuye K., Chem. Pharm. Bull., 45, 2043-2050 (1997).
2. Hansrani P. K., Davis S. S., Groves M. J., J. Parenteral Sci. Technol., 37, 145-150 (1983).
3. Wisse E., J. Ultrstruct. Res., 31, 125-150 (1970).
4. a) Allen T. M., Everest J. M., J. Pharmacol. Exp. Ther., 226, 539-544 (1983);
5. b) Senior J. H., Crit. Rev. Ther. Drug Carrier Syst., 3, 123-193 (1987);
6. c) Sato Y., Kiwada H., Kato Y., Chem. Pharm. Bull., 34, 4244-4252 (1986);
7. d) Woodle M. C., Lasic D. D., Biochim. Biophys. Acta, 1113, 171-199 (1992).
8. a) Hnatowich D. J., Friedman B., Clancy B., Novak M., J. Nucl. Med., 22, 810-814 (1981);
9. b) Kabalka G. W., Davis M. A., Moss T. H., Buonocore E., Hubner K., Holmberg E., Maruyama K., Huang L., Magn. Reson. Med., 19, 406-415 (1991).
10. Ilum L., West P., Washington C., Davis S. S., Int. J. Pharm., 54, 41-49 (1989).
11. Sakaeda T., Hirano K., J. Drug Target., 3, 221-230 (1995).
12. a) Yanai S., Okada H., Saito K., Kuge Y., Ogawa Y., Toguchi H., Int. J. Pharm., 123, 237-245 (1995);
13. b) Natsume H., Imamizu M., Sugibayashi K., Shibata T., Miyagawa A., Morimoto Y., Chem. Pharm. Bull., 40, 1545-1552 (1992).
14. Shively M. L., Pharm. Res., 10, 1153-1156 (1993).
15. Lieberman H. A., Rieger M. M., Banker G. S. (ed.), "Pharmaceutical Dosage Forms - Dispersion Systems," Vol. 1, 2nd ed., Marcel Dekker, Inc., New York, 1996, pp. 53-90.
16. a) Allen T. M., Chonn A., FEBS Lett., 223, 42-46 (1987);
17. b) Klibanov A. L., Maruyama K., Torchilin V. P., Huang L., ibid., 268, 235-237 (1990);
18. c) Blume G., Cevc G., Biochim. Biophys. Acta, 1029, 91-97 (1990);
19. d) Allen T. M., Hansen C., Martin F., Redemann C., Young A. Y., ibid., 1066, 29-36 (1991);
20. e) Maruyama K., Yuda T., Okamoto A., Kojima S., Suginaka A., Iwatsuru M., ibid., 1128, 44-49 (1992)
21. a) Palmer T. N., Caride V. J., Caldecourt M. A., Twicker J., Abdullah V., Biochim. Biophys. Acta, 797, 363-368 (1984);
22. b) Gabizon A., Adv. Drug Deliv. Rev., 16, 285-294 (1995).
23. a) Klibanov A. L., Maruyama K., Beckerleg A. M., Torchilin V. P., Huang L., Biochim. Biophys. Acta, 1062, 142-148 (1991);
24. b) Blume G., Cevc G., ibid., 1146, 157-168 (1993);
25. c) Maruyama K., Unezaki S., Takahashi N., Iwatsuru M., ibid., 1149, 209-216 (1993).